Gregory W. Matz - 21 Jun 2023 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Role
Director
Signature
/s/Lisa Walters-Hoffert, Attorney-in-fact
Issuer symbol
DARE
Transactions as of
21 Jun 2023
Transactions value $
$0
Form type
4
Filing time
21 Jun 2023, 21:38:14 UTC
Previous filing
24 Jun 2022
Next filing
15 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DARE Stock Option (right to buy) Award $0 +40K $0.00 40K 21 Jun 2023 Common stock 40K $0.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.